Zealand Pharma A/S | ZEAL - Eps Gewinn Pro Aktie

Aktienkurs
265.10
Täglich Wechseln
2.30 0.88%
Monatlich
-32.04%
Jährlich
-54.72%
Q1 Prognose
222.73




Eps Veränderung Datum
Akebia Therapeutics USD 0.03 0.13 2025-03
Alaunos Therapeutics USD -0.53 0.07 2025-09
Avita Medical AUD -0.38 0 2025-12
Dianthus Therapeutics USD -0.97 0.09 2025-09
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
IQVIA Holdings USD 3.42 0.42 2025-12
Moderna USD -2.11 1.6 2025-12
Organon & Co USD 0.63 0.38 2025-12
Revvity USD 1.7 0.52 2025-12
Tectonic Therapeutic USD -1.02 0.05 2025-09
Tilray USD -0.41 0.4 2025-12
Viatris USD 0.57 0.1 2025-12
Xeris Pharmaceuticals USD 0 0.02 2025-09